“A Predictive In vitro Biorelevant Dissolution Method Development for Fluvoxamine Extended-Release Capsules by Simulating Preprandial and Postprandial In vivo Performance”, AJP, vol. 14, no. 4, Nov. 2020, doi: 10.22377/ajp.v14i4.3820.